Neutrophil activation by nanomaterials in vitro: comparing strengths and limitations of primary human cells with those of an immortalized (HL-60) cell line. Issue 1 (2nd January 2021)

• Record Type: Journal Article
• Authors: Verdon, Rachel; Gillies, Suzanne L.; Brown, David M.; Henry, Theodore; Tran, Lang; Tyler, Charles R.; Rossi, Adriano G.; Stone, Vicki; Johnston, Helinor J.
• Is Part Of: Nanotoxicology. Volume 15:Issue 1(2021)
• Page Start: 1
• Page End: 20
• Publication Date: 2021-01-02
• Subjects: Neutrophil -- nanomaterial -- inflammation -- in vitro -- nanotoxicology; Toxicology -- Periodicals; 615.9
• DOI: 10.1080/17435390.2020.1834635
• Languages: English
• ISSNs: 1743-5390

Abstract

Abstract: Assessment of nanomaterial (NM) induced inflammatory responses has largely relied on rodent testing via measurement of leukocyte accumulation in target organs. Despite observations that NMs activate neutrophil driven inflammatory responses in vivo, a limited number of studies have investigated neutrophil responses to NMs in vitro . We compared responses between the human neutrophil-like HL-60 cell line and human primary neutrophils following exposure to silver (Ag), zinc oxide (ZnO), copper oxide (CuO) and titanium dioxide (TiO2 ) NMs. NM cytotoxicity and neutrophil activation were assessed by measuring cellular metabolic activity, cytokine production, respiratory burst, and release of neutrophil extracellular traps. We observed a similar pattern of response between HL-60 cells and primary neutrophils, however we report that some neutrophil functions are compromised in the cell line. Ag NMs were consistently observed to stimulate neutrophil activation, with CuO NMs inducing similar though weaker responses. TiO2 NMs did not induce a neutrophil response in either cell type. Interestingly, ZnO NMs readily induced activation of HL-60 cells but did not appear to activate primary cells. Our findings are relevant to the development of a tiered testing strategy for NM hazard assessment which promotes the use of non-rodent models. Whilst we acknowledge that HL-60 cells may not be a perfect substitute for primary cells and require further investigation regarding their ability to predict neutrophil activation, we recommend their use for initial screening of NM-induced inflammation. Primary human neutrophils can then be used for more focused assessments of neutrophil activation before progressing to in vivo models where necessary.